Avion Wealth Supernus Pharmaceuticals, Inc. Transaction History
Avion Wealth
- $362 Million
- Q2 2024
A detailed history of Avion Wealth transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Avion Wealth holds 43 shares of SUPN stock, worth $1,376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 43
-0.0%
Holding current value
$1,376
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SUPN
# of Institutions
256Shares Held
59.3MCall Options Held
47.9KPut Options Held
13.1K-
Black Rock Inc. New York, NY10.4MShares$333 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.14MShares$196 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.27MShares$169 Million1.83% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$91.7 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.68MShares$85.8 Million0.08% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.71B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...